Targeting RET Kinase in Neuroendocrine Prostate Cancer

The increased treatment of metastatic castration resistant prostate cancer (mCRPC) with second-generation anti-androgen therapies (ADT) has coincided with a greater incidence of lethal, aggressive variant prostate cancer (AVPC) tumors that have lost dependence on androgen receptor (AR) signaling. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Res
Main Authors: VanDeusen, Halena R., Ramroop, Johnny R., Morel, Katherine L., Bae, Song Yi, Sheahan, Anjali V., Sychev, Zoi, Lau, Nathan A., Cheng, Larry C., Tan, Victor M., Li, Zhen, Petersen, Ashley, Lee, John K., Park, Jung Wook, Yang, Rendong, Hwang, Justin H., Coleman, Ilsa, Witte, Owen N., Morrissey, Colm, Corey, Eva, Nelson, Peter S., Ellis, Leigh, Drake, Justin M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7415621/
https://ncbi.nlm.nih.gov/pubmed/32461304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-1245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados